Successful dupilumab treatment for omalizumab-refractory chronic spontaneous urticaria with GATA3+ cell infiltration

European Journal of Dermatology · Published 2026-06-01 · DOI 10.1684/ejd.2026.5084

Authors (4)

Kaho Shirai, Takahiro Suzuki, Yuka Nagakura, Tetsuya Honda

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Shirai, K., Suzuki, T., Nagakura, Y., et al. (2026). Successful dupilumab treatment for omalizumab-refractory chronic spontaneous urticaria with GATA3+ cell infiltration. European Journal of Dermatology. https://doi.org/10.1684/ejd.2026.5084

Related articles